Skip to content

Clinical trials

Recruiting Phase 1 Cognitive Dysfunction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 1 Status: Recruiting Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20213
20221
20232
20242
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
National Institute of Mental Health (NIMH)2
Amyloid Solution Inc1
Butler Hospital1
Johns Hopkins University1
Massachusetts General Hospital1
NYU Langone Health1
Oregon Health and Science University1
Pravat Mandal1
Regeneron Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction17
Alzheimer Disease10
Dementia3
Inflammation2
Neurodegenerative Diseases2
Parkinson Disease2
Anemia, Sickle Cell1
Attention Deficit Disorder with Hyperactivity1
Brain Diseases1
Central Nervous System Diseases1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.